CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)

被引：0

作者：

Uchio, Edward M. ^{[1
]}

Li, Roger ^{[2
]}

Steinberg, Gary ^{[3
]}

Lamm, Donald ^{[4
]}

Kamat, Ashish ^{[5
]}

Packiam, Vignesh ^{[6
]}

Anderson, Paul ^{[7
]}

Ku, Ja Hyeon ^{[8
]}

Chisamore, Michael ^{[9
]}

McAdory, John ^{[10
]}

Hnat, Nataliya ^{[10
]}

Kim, Jee-Hyun ^{[10
]}

Grandi, Paola ^{[10
]}

Burke, James ^{[10
]}

机构：

[1] UCI, Irvine, CA USA

[2] Moffit Canc Ctr, Tampa, FL USA

[3] NYU Langone Hlth, New York, NY USA

[4] BCG Oncol, Phoenix, AZ USA

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[6] Univ Iowa Hlth Care, Iowa City, IA USA

[7] Royal Melbourne Hosp, Melbourne, Australia

[8] Seoul Natl Univ Hosp, Seoul, South Korea

[9] Merck, Rahway, NJ USA

[10] UCI, CaliforniaCG Oncol, Irvine, CA USA

来源：

CANCER SCIENCE | 2023年 / 114卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

S21-4

引用

页码：1587 / 1587

页数：1

共 50 条

[21] BACILLUS CALMETTE-GUERIN (BCG) THERAPY IS SAFE AND EFFECTIVE IN NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS WITH IMMUNOSUPPRESSIVE CONDITIONS
Durant, Adri
Choudry, Mouneeb
Madura, Grace
Mi Lanyu
Tyson, Mark
Faraj, Kassem
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S59 - S59
[22] Bacillus Calmette-Guerin (BCG) unresponsive non-muscle-invasive bladder cancer: are the subgroups equal?
Tan, Wei Shen
Grajales, Valentina
Bree, Kelly
Li, Roger
Nogueras-Gonzalez, Graciela M.
Navai, Neema
Dinney, Colin
Kamat, Ashish M.
BJU INTERNATIONAL, 2023, 132 (04) : 384 - 386
[23] HEALTHCARE RESOURCE USE (HCRU) OF NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS POST BACILLUS CALMETTE-GUERIN (BCG)-UNRESPONSIVE STATUS IN MULTIPLE COUNTRIES
Broughton, E.
Chun, D.
Gooden, K.
Mycock, K.
Rajkovic, I
Taylor-Stokes, G.
VALUE IN HEALTH, 2020, 23 : S484 - S485
[24] LONG-TERM COST-EFFECTIVENESS OF NADOFARAGENE FIRADENOVEC AND OPORTUZUMAB MONATOX FOR TREATMENT OF BACILLUS CALMETTE-GUERIN (BCG)-UNRESPONSIVE, NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
Joshi, M.
Atlas, S. J.
Rind, D. M.
Beinfeld, M.
McKenna, A.
Patel, S.
Chapman, R. H.
Pearson, S.
Touchette, D.
VALUE IN HEALTH, 2021, 24 : S33 - S33
[25] Treatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studies
Kiselyov, Alex
Bunimovich-Mendrazitsky, Svetlana
Startsev, Vladimir
BBA CLINICAL, 2015, 4 : 27 - 34
[26] Treatment strategies for the Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
Jeong, Seung-hwan
Ku, Ja Hyeon
INVESTIGATIVE AND CLINICAL UROLOGY, 2023, 64 (02) : 103 - 106
[27] Immunotherapy in Bacillus Calmette-Guerin (BCG) unresponsive nonmuscle invasive bladder cancer
Hugar, Lee A.
Gilbert, Scott M.
Sexton, Wade J.
Kamat, Ashish M.
Li, Roger
CURRENT OPINION IN UROLOGY, 2021, 31 (02) : 160 - 169
[28] Letter to the Editor: Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
Li, Roger
Sylvester, Richard
Dinney, Colin P.
Kamat, Ashish M.
BLADDER CANCER, 2017, 3 (03) : 147 - 148
[29] Real-world treatment patterns among patients with non-muscle invasive bladder cancer (NMIBC) treated with intravesical Bacillus Calmette-Guerin (BCG)
Kumar, Neela
Balaji, Hiremagalur Parthasarathy
Emond, Bruno
Manceur, Ameur M.
Ghelerter, Isabelle
Pilon, Dominic
Lefebvre, Patrick
Imran, Nida Shafaat
Ellis, Lorie
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 404 - 404
[30] UTILITY OF RESCUE BACILLUS CALMETTE-GUERIN THERAPY IN TREATMENT OF BCG-UNRESPONSIVE NON-MUSCLE- INVASIVE BLADDER CANCER
Ketty, Bai
Srinath-Reddi, Pingle
Rainjade, Chung
Benjamin, I. Joffe
Caroline, Laplaca
Joel, Decastro G.
James, M. McKiernan
Christopher, B. Anderson
Andrew, T. Lenis
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)

← 1 2 3 4 5 →